Abiopharma

Press Release: DiaMedica Therapeutics Reports First Quarter 2025 Financial Results And Provides Business Highlights

iTeos verkündet Topline-Zwischenergebnisse der GALAXIES Lung-201-Studie für die First-Line-Behandlung mit Belrestotug und Dostarlimab von Krebspatienten, die von einem nicht-kleinzelligen Lungenkarzinom mit hoher PD-L1-Expression betroffen sind

iTeos annonce les premiers résultats provisoires de l’étude GALAXIES Lung-201 portant sur l’association belrestotug + dostarlimab en traitement de première intention des patients atteints d’un cancer du poumon non à petites cellules et présentant un taux de PD-L1 élevé

New Press Release from Annovis Bio

Alcon - Alcon Reports First-Quarter 2025 Results and Launches Transformational Change in Ophthalmic Surgery with Unity VCS

Alcon Reports First-Quarter 2025 Results and Launches Transformational Change in Ophthalmic Surgery with Unity VCS

MeiraGTx Announces the Presentation of Four Posters at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting

DiaMedica Therapeutics Reports First Quarter 2025 Financial Results And Provides Business Highlights

Annovis Provides Corporate Updates and Reports First Quarter 2025 Financial Results

Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial Results